# LENZ Therapeutics, Inc.: Form SCHEDULE 13D/A, filed May 9, 2025

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: SCHEDULE 13D/A
- Filed: 2025-05-09
- Accepted by EDGAR: May 9, 2025, 20:19 ET
- Period: not reported
- Accession: 0001415889-25-012499
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000141588925012499/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000141588925012499/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000141588925012499/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 9, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-012499. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.